ロード中...

Epigenetics in Brain Tumors: HDACs Take Center Stage

Primary tumors of the brain account for 2 % of all cancers with malignant gliomas taking the lion’s share at 70 %. Malignant gliomas (high grade gliomas WHO° III and °IV) belong to one of the most threatening tumor entities known for their disappointingly short median survival time of just 14 months...

詳細記述

保存先:
書誌詳細
出版年:Curr Neuropharmacol
主要な著者: Eyüpoglu, Ilker Y., Savaskan, Nicolai E.
フォーマット: Artigo
言語:Inglês
出版事項: Bentham Science Publishers 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4787285/
https://ncbi.nlm.nih.gov/pubmed/26521944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666151030162457
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!